NEWSROOM
MEDIA
ABBOTT INDIA LTD
PRODUCTS
CAREERS
ABOUT ABBOTT
Business: GenNext
MOLECULE: Cholecalciferol
FORM: Solution
STRENGTH: 2000 IU/5ml
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED
THERAPY AREAS: OTHERS
Business: Abbott India Limited
MOLECULE: Ebastine
FORM: Tablet
STRENGTH: 10 mg, 20 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,ALLERGY,NEUROSCIENCE
THERAPY AREAS: NEUROSCIENCE
MOLECULE: Sodium Chloride
FORM: Spray
STRENGTH: 0.90 % 100 ml
MOLECULE: Sodium Bicarbonate + Sodium Citrate Anhydrous + Tartaric Acid + Citric Acid Anhydrous + Flavoured excipients q.s. also contains Saccharin Sodium IP as sweetener
FORM: Powder
STRENGTH: Contains: Sodium Bicarbonate IP 44.03%, Sodium Citrate Anhydrous USP 15.75% , Tartaric Acid IP 22.25% , Citric Acid Anhydrous IP 17.88%, Flavoured excipients q.s. also contains Saccharin Sodium IP as sweetener.
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,CONSUMER CARE
THERAPY AREAS: CONSUMER CARE
MOLECULE: Citric acid + Sodium Bicarbonate
STRENGTH: Ingredients (per 5g) : Svarjiksara(Shuddh)2.83g Nimbukamlam(Shushkam)1.97g Contains permitted sweetener , sodium saccharin15mg/5g and permitted colour : Tartrazine, added flavour q.s.
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,CONSUMER CARE
MOLECULE: Magnesium Hydroxide + simethicone + Sodium Carboxymethylcellulose + Dried Aluminium Hydroxide Gel + Sugarfree base
FORM: Gel
STRENGTH: Each 10 ml contains: Magnesium Hydroxide I.P 185 mg (added as paste) simethicone I.P 50 mg Sodium Carboxymethylcellulose I.P 100 mg Dried Aluminium Hydroxide Gel I.P.830 mg (added as paste)
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTROENTEROLOGY,CONSUMER CARE
MOLECULE: Dried Aluminium Hydroxide Gel Magnesium+ Al. Silicate Hydrate + Magnesium Hydroxide + Simethicone
FORM: Chewable Tablets
STRENGTH: Each uncoated chewable TABLETlet contains: Dried Aluminium Hydroxide Gel I.P. 300 mg Magnesium Al. Silicate Hydrate I.P. 50 mg Magnesium Hydroxide I.P. 25 mg Simethicone I.P. 25 mg
MOLECULE: Benzalkonium Chloride + Zinc Oxide + Cream base q.s.
FORM: Cream
STRENGTH: Each gram contains: Benzalkonium ChlorideI.P. 0.1%w/w Zinc Oxide I.P. 8.5%w/w Cream base q.s.
MOLECULE: Ilaprazole
STRENGTH: 10 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTROENTEROLOGY,GASTRO
THERAPY AREAS: GI & HEPATO,GASTRO
MOLECULE: Mebeverine Hydrochloride
STRENGTH: 135 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTROENTEROLOGY,GI & HEPATO
THERAPY AREAS: GI & HEPATO
MOLECULE: Liquid paraffin + milk of magnesia + sodium picosulphate
FORM: Emulsion
STRENGTH: 1.25 ML + 3.75 ML + 3.33 MG IN 200 ML
MOLECULE: Liquid paraffin + milk of magnesia
STRENGTH: 3.75 ML + 11.25 ML IN 200 ML,450 ML
MOLECULE: Diltiazem Hydrochloride
STRENGTH: 2% w/w IN 30 G
MOLECULE: Sodium picosulphate
MOLECULE: Pinaverium Bromide
STRENGTH: 50 mg
MOLECULE: Itopride hydrochloride
FORM: Capsule
STRENGTH: 150mg
MOLECULE: Itopride Hydrochloride + Pantoprazole Sodium salt
STRENGTH: 150mg, 40mg
MOLECULE: Ademetionine
STRENGTH: Ademetionine 1, 4-butane disulfonate (SD4) equivalent to Ademetionine lon 400mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTROENTEROLOGY,HEPATIC
THERAPY AREAS: GI & HEPATO,HEPATIC
MOLECULE: Dimeticone + Pancreatin
STRENGTH: 80mg, 170mg
MOLECULE: Mesalazine
FORM: Pellet
STRENGTH: 1 g, 500mg
MOLECULE: Ursodeoxycholic acid
STRENGTH: 150 mg; 300 mg; 600 mg
MOLECULE: Chlordiazepoxide + Mebeverine Hydrochloride
STRENGTH: Mebeverine Hydrochloride 135mg & Chlordiazepoxide 5mg
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,GI & HEPATO
FORM: Cap
STRENGTH: 200mg
MOLECULE: Pancreatin
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GI & HEPATO
STRENGTH: 300mg
STRENGTH: 400mg
MOLECULE: Lactulose
FORM: Oral Solution
STRENGTH: 3.335g / 5ml (SKU - 100ml, 150ml, 200ml, 250ml, 450ml)
MOLECULE: Acotiamide
STRENGTH: 100mg
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTRO
THERAPY AREAS: GASTRO
MOLECULE: Lactitol + Plantago psyllium
FORM: Granules
STRENGTH: 10G, 3.5 G IN 90G
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GASTRO
MOLECULE: Plantago ovata powder
STRENGTH: 4.8 G in 5G IN 140 G, 300 G
MOLECULE: Ofloxacin + Ornidazole
STRENGTH: 200 MG, 500 MG
MOLECULE: Bifidobacterium Bifidus + Lactobacillus Acidophilus + Lactobacillus Casei + Lactobacillus Plantarum + Lactobacillus Reuteri+ Lactobacillus Rhamnosus + Saccharomyces Boulardii
MOLECULE: Chlordiazepoxide + Clidinium bromide
STRENGTH: 5mg,2.50mg
FORM: Drops
STRENGTH: 400 IU/ 0.5ml 15 ml
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GENNEXT
THERAPY AREAS: GENNEXT
STRENGTH: 60 K / 5 ml
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,GENNEXT
FORM: Ampoule
STRENGTH: 300 K 1 ml,600 K 1 ml
MOLECULE: Bacillus Clausii
FORM: Suspension
STRENGTH: 2 BILLION / 5 ML
MOLECULE: Ibuprofen + Tizanidine
STRENGTH: 400 mg+ 2 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,PAIN-MANAGEMENT,GENNEXT
THERAPY AREAS: PAIN MGMT,GENNEXT
MOLECULE: Ibuprofen
STRENGTH: 200mg; 400mg; 600mg
STRENGTH: 100 mg/5 ml
MOLECULE: 2 Octyl-Cyanoacrylate
FORM: Vial
STRENGTH: 0.36 ML
MOLECULE: Magnesium Hydroxide + Aluminium Hydroxide + Simethicone
STRENGTH: Each 5ml of antacid anesthetic formaulation contains : Magnesium Hydroxide I.P.(added as paste) 300mg Dried Aluminium Hydroxide Gel I.P. (added as paste) 600mg Simethicone I.P. 25mg Oxetacaine BP 10mg
MOLECULE: Isoxsuprine Hydrochloride
STRENGTH: 40 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,WOMEN'S HEALTH,GENNEXT
THERAPY AREAS: WOMEN'S HEALTH,GENNEXT
STRENGTH: 10 mg 2 ml
MOLECULE: Fructooligsaccharides + Soya Isoflavones
STRENGTH: 200 g
MOLECULE: Multivitamin
FORM: Syrup
STRENGTH: 200 ml
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,VITAMINS,GENNEXT
MOLECULE: Amoxicillin Trihydrate + Clavulanic acid Potassium salt
STRENGTH: 250+125 mg, 200+28.5 mg, 500+125 mg, 875+125 mg
THERAPY AREAS: ANTI-INFECTIVES
FORM: Dry Syrup
STRENGTH: Each 5ml contains : 200+28.5 ; 400+57
THERAPY AREAS: ANTI-INFECTIVES,GENNEXT
MOLECULE: Dextromethorpan + Chlorpheniramine Maleate
STRENGTH: Each 1ml contains:Dextromethorphan 5mg + Chlorpheniramine 1mg (60 ML)
THERAPY AREAS: RESPIRATORY,GENNEXT
MOLECULE: Calcium Citrate + Vitamin D3
STRENGTH: 250 + 400 IU
MOLECULE: Calcium Citrate + Calcitriol
STRENGTH: 250 + 0.25
MOLECULE: Aceclofenac + Thiocolchiocoside
STRENGTH: 100 + 4 mg, 100 + 8 mg
MOLECULE: Thiocolchicoside
STRENGTH: 4 mg, 8 mg
MOLECULE: Zolpidem Tartrate
STRENGTH: 12.5 MG, 6.25 MG
STRENGTH: 5 mg; 10mg
THERAPY AREAS: NEURO-PSYCHIAT,GENNEXT
MOLECULE: Daclatasvir Hydrochloride
STRENGTH: Daclatasvir Dihydrochloride equivalent to Daclatasvir 60mg
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,HEPATIC
THERAPY AREAS: HEPATIC
MOLECULE: Rifaximin
STRENGTH: Rifaximin Ph. Eur. 550mg (Colours : Sunset Yellow FCF & Titanium Dioxide), Rifaximin Ph. Eur. .400mg (Colours : Sunset Yellow FCF & Titanium Dioxide)
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,HEPATIC
STRENGTH: 300ml, Each 5 ml contains - Lactulose Solution USP equivalent to Lactulose 3.335 g
STRENGTH: 200 ml, each 5ml contains - Lactulose Concentrate USP Equivalent to Lactulose 2.5g In aqueous wheat dextrin base ...q.s.
MOLECULE: Ledipasvir + Sofosbuvir
STRENGTH: Ledipasvir 90mg + Sofosbuvir 400mg
MOLECULE: Tenofovir Disoproxil Fumarate
STRENGTH: Tenofovir Disoproxil Fumarate I.P. 300mg
MOLECULE: Sofosbuvir
MOLECULE: Calcium + Colecalciferol
STRENGTH: Calcium Carbonate 1.25 g + Vit D3 500IU
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,METABOLICS
THERAPY AREAS: METABOLICS
MOLECULE: Terazosin hydrochloride
STRENGTH: 2 mg,1 mg,5 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,THYROID-DIABETES & UROLOGY,METABOLICS
THERAPY AREAS: CARDIO-DIABETO,METABOLICS
MOLECULE: Glimepiride + Metformin Hydrochloride
STRENGTH: 1 mg,2 mg,500 mg,1000 mg
MOLECULE: Metformin Hydrochloride + Voglibose
STRENGTH: 0.20 MG,0.30 MG, Metformin 500mg
MOLECULE: Metformin Hydrochloride
STRENGTH: 1000 MG,500 MG
MOLECULE: Traditional Indian ayurvedic medicine
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,METABOLICS
MOLECULE: Doconexent + Folic acid + Icosapent + Lycopene + Magnesium+ Manganese + Picolinic acid chromium salt + Pyridoxine Hydrochloride + Thioctic acid + Zinc Sulfate
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,METABOLICS,VITAMINS
MOLECULE: Carbimazole
STRENGTH: 5 mg; 10 mg; and 20 mg
THERAPY AREAS: HORMONES,METABOLICS
STRENGTH: CCM 250mg + Vit D3 400IU
MOLECULE: Levothyroxine Sodium
STRENGTH: 100 Y,12.5 Y,125 Y,150 Y,25 Y,50 Y,62.5 Y,75 Y,112 Y,137 Y,88 Y
MOLECULE: Cyanocobalamin + Folic acid + Iron Ferrous Fumarate + Selenious acid + Tyrosine+ Zinc Sulfate
MOLECULE: Prochlorperazine Maleate
STRENGTH: 5 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,NEUROSCIENCE
MOLECULE: Phenytoin
FORM: Ampule
STRENGTH: 50 MG 10 ML ,50 MG 2 ML
THERAPY AREAS: NEURO-PSYCHIAT,NEUROSCIENCE
STRENGTH: 30 MG 200 ML
THERAPY AREAS: NEURO-PSYCHIAT
STRENGTH: 300 MG (ER) ,100 MG,50 MG
MOLECULE: Propranolol Hydrochloride
STRENGTH: 20 MG,40 MG
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,NEUROSCIENCE
STRENGTH: 10 mg; 40 mg
MOLECULE: Lacosamide
STRENGTH: 100mg, 200mg, 50mg
FORM: Injection
STRENGTH: 10mg / ml
MOLECULE: Levitracetam
STRENGTH: 100 mg 5 ML
FORM: Liquid
STRENGTH: 100 mg 100 ml
MOLECULE: Dosulepin Hydrochloride + Mecobalamin
STRENGTH: 50 mg+ 1500 mcg, 75 mg+ 1500 mcg
MOLECULE: Benfotiamine + Folic acid + Inositol + Mecobalamin + Chromium Polynichotinate + Pyridoxine Hydrochloride + Alpha lipoic acid
MOLECULE: Betahistine Hydrochloride
STRENGTH: 48 mg,24 mg
STRENGTH: 16 MG,24 MG,8 MG
MOLECULE: Each 5 ml (one teaspoonful approx.) contains: Ibuprofen IP 100 mg in an orange flavored syrupy base. Color: Sunset Yellow FCF
STRENGTH: 60ml
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,PAIN-MANAGEMENT
THERAPY AREAS: PAIN MGMT
MOLECULE: Flurbiprofen I.P. 5% w/w In a gel base containing Menthol & Methyl Salicylate
STRENGTH: 5% w/w
MOLECULE: Calcium Citrate Malate + Vitamin D3
FORM: Tab
STRENGTH: 250 mg & 400 IU
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,VITAMINS,WOMEN'S HEALTH
THERAPY AREAS: WOMEN'S HEALTH
MOLECULE: Vitamin B Complex
STRENGTH: Each 15 ml (1 tablespoonful approx.) contains: Nicotinamide IP 45 mg, Pyridoxine Hydrochloride IP 1.5 mg, Cyanocobalamine IP 5 mcg, Zinc (as Zinc sulphate IP) 10 mg, Lysine Hydrochloride USP 100 mg, Alcohol (95%) IP 1.425 ml, Non Syrupy Base q.s. to 15 ml, Contains Absolute Alcohol IP 9 % v/v, Appropriate overages of vitamins added. Colour: Carmoisine WS
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,VITAMINS
MOLECULE: Multivitamin & Minerals
FORM: Softlet
STRENGTH: Vitamin B6 (Pyridoxine Hydrochloride) IP 3.0 mg, Nicotinamide IP 100 mg, B12 (Cyanacobalamin) IP 15 mcg, Folic acid IP.1.5 mg, Chromium Picolinate USP 250 mcg, Selenium (as selenious acid USP) 100 mcg, Zinc Sulphate Monohydrate USP 61.8 mg, Lycopene (10%) 5 mg
MOLECULE: Ferrous Fumarate I.P.equivalent to elemental iron , Folic Acid Vitamine B12 , L-Tyrosine , Selenious Acid USP equivalent to elemental Selenium , Zinc Sulphate Monohydrate USP equivalent to elemental Zinc15mg
STRENGTH: Ferrous Fumarate I.P.equivalent to elemental iron 30mg Folic Acid I.P. 300mcg Vitamine B12 I.P. 1mcg L-Tyrosine USP 250mg Selenious Acid USP equivalent to elemental Selenium 60mcg Zinc Sulphate Monohydrate USP equivalent to elemental Zinc15mg
MOLECULE: Vi-Capsular Polysaccharide of S. typhi Ty2 conjugated to Tetanus Toxoid + Sodium chloride + water
FORM: Pre Filled Syringe
STRENGTH: Each 0.5 mL prefilled syringe contains purified Vi-Capsular Polysaccharide of S. typhi Ty2 conjugated to Tetanus Toxoid 25 μg, Sodium chloride 4.5 mg and water for Injections q.s. to 0.5 mL.
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,VACCINE
THERAPY AREAS: RESPIRATORY,VACCINE
MOLECULE: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181)+ A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) + B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type)
FORM: Pre filled Syringe
STRENGTH: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181) 7.5 mcg HA, A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) 7.5 mcg HA, B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type) 7.5 mcg HA per 0.25 mL dose. This vaccine complies with the WHO recommendation (northern hemisphere) and competent authority decision for the 2016/2017 season.
THERAPY AREAS: VACCINE
STRENGTH: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181) 15 mcg HA, A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) 15 mcg HA, B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type) 15 mcg HA per 0.5 mL dose. This vaccine complies with the WHO recommendation (northern hemisphere) and competent authority decision for the 2016/2017 season.
MOLECULE: Purified, inactivated Japanese Encephalitis Virus protein (JE strain 821564-XY) + Aluminum Hydroxide gel + Thiomersal (Preservative) + Phosphate buffered saline
STRENGTH: Each Dose of 0.5 mL contains: Purified, inactivated Japanese Encephalitis Virus protein NLT 5.0 μg (JE strain 821564-XY), Aluminum Hydroxide gel as Al+++ IP 0.25 mg, Thiomersal (Preservative) IP 0.025 mg, Phosphate buffered saline q.s. to 0.5 ml.
MOLECULE: Diphtheria Toxoid + Tetanus Toxoid + B. pertussis (Whole cell inactivated) + HBsAg (rDNA) + Hib PRP-TT Conjugate + Aluminium Phosphate gel as Aluminium (Al+++) + Thiomersal
STRENGTH: Pre-filled syringe of 0.5 ml. Each syringe contains Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Influenzae type b Conjugate Vaccine (Adsorbed) I.P. Each dose of 0.5 mL contains: Diphtheria Toxoid 20 Lf to <30 Lf ( 30 IU), Tetanus Toxoid 5 Lf to 25 Lf ( 60 IU), B. pertussis (Whole cell inactivated) 4 IU, HBsAg (rDNA) 10 μg, Hib PRP-TT Conjugate 10 μg, Aluminium Phosphate gel as Aluminium (Al+++) 0.3 mg, Thiomersal IP 0.021 mg to 0.029 mg.
THERAPY AREAS: GI & HEPATO,VACCINE
MOLECULE: Rotavirus 116E NLT 105.0 FFU + Potassium phosphate monobasic + Potassium phosphate dibasic + Sucrose + Potassium L-glutamate monohydrate + Neomycin sulphate + Kanamycin sulphate + Dulbecco’s Modi ed Eagle’s Medium + water
STRENGTH: Each 0.5 ml contains Rotavirus 116E NLT 105.0 FFU, Potassium phosphate monobasic IP 0.258 mg, Potassium phosphate dibasic IP 0.625 mg, Sucrose IP 37.31 mg, Potassium L-glutamate monohydrate 1.0 mg, Neomycin sulphate IP 15 μg, Kanamycin sulphate IP 15 μg, Dulbecco’s Modi ed Eagle’s Medium 4.4 mg and water for Injection IP q.s, pH is in the range of 7.2 to 8.0.
MOLECULE: Clomifene Citrate IP
STRENGTH: 25 mg; 50 mg; 100 mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,WOMEN'S HEALTH
MOLECULE: Dydrogesterone
MOLECULE: Estradiol(as Hemihydrate)
STRENGTH: 1mg, 2mg
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,WOMEN'S HEALTH
MOLECULE: Dydrogesterone + Estradiol
STRENGTH: Estradiol 1 mg/ dydrogesterone-5 mg
STRENGTH: (Combipack of estradiol/dydrogesterone) 1mg/1-10 mg
MOLECULE: Cyanocobalamin + Folic acid + Ferrous Ascorbate + Zinc Sulfate
MOLECULE: Sodium Feredetate + Vitamin B12+ Folic acid
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size.
Asset Warning